Reach Us +44-1235-425476
Biosimilars: Accelerating Early Clinical Development | 70769
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Biosimilars: Accelerating early clinical development

8th Asian Biologics and Biosimilars Congress

Raymond A Huml

Quintiles IMS, USA

Keynote: J Bioanal Biomed

DOI: 10.4172/1948-593X-C1-031

This presentation will discuss how early clinical development with biosimilars is paramount to later development and registration success. It will provide an overview of ECD services successfully used for implementing Phase-I biosimilar trials in Asia Pacific as well as the West (e.g., US and EU) for global registrations. It will present an overview of site selection and feasibility data using a Next Generation approach driven by IMS legacy data to aid recruitment especially in tough areas to recruit patients for biosimilar trials such as the US and Europe. Finally, a model to accelerated biosimilar development will be presented that has been successfully used by one of the world’s largest providers of pharmaceutical services.

Raymond A Huml is the Vice President, Strategic Drug Development and Head, Global Biosimilars Strategic Planning at QuintilesIMS. He has written over 60 articles on a variety of subjects and three books. He has more than 27 years of experience in the biopharmaceutical and healthcare industries and holds an MS in Biology from East Stroudsburg University, a DVM from the North Carolina State University College of Veterinary Medicine and has earned the RAC (US) certification.

Email: [email protected]